tiprankstipranks
Advertisement
Advertisement

ADIL Stock Latest News

Adial Pharmaceuticals Completes Azora Merger, Shifts Strategic Focus
Company AnnouncementsAdial Pharmaceuticals Completes Azora Merger, Shifts Strategic Focus
17h ago
8K
ADIL
Adial Pharmaceuticals announces acquisition of Azora Therapeutics
PremiumThe Fly
Adial Pharmaceuticals announces acquisition of Azora Therapeutics
18h ago
ADIL
Adial Pharmaceuticals: Buy Rating Reiterated as AD04’s Precision AUD Strategy Advances; $8 Price Target Maintained
PremiumRatings
Adial Pharmaceuticals: Buy Rating Reiterated as AD04’s Precision AUD Strategy Advances; $8 Price Target Maintained
30d ago
ADIL
Adial Pharma’s Strategic Options: High-Stakes Search for a Deal Puts Share Price and Long-Term Prospects at Risk
PremiumCompany Announcements
Adial Pharma’s Strategic Options: High-Stakes Search for a Deal Puts Share Price and Long-Term Prospects at Risk
1M ago
ADIL
Adial Pharmaceuticals files AD04 utility application with USPTO
PremiumThe Fly
Adial Pharmaceuticals files AD04 utility application with USPTO
1M ago
ADIL
Adial submits AD04 product application for FDA CNPV pilot program
PremiumThe FlyAdial submits AD04 product application for FDA CNPV pilot program
2M ago
ADIL
Adial Pharmaceuticals completes AD04 demonstration batch production
Premium
The Fly
Adial Pharmaceuticals completes AD04 demonstration batch production
2M ago
ADIL
Adial Pharmaceuticals Implements New Executive Equity Compensation Plan
Premium
Company Announcements
Adial Pharmaceuticals Implements New Executive Equity Compensation Plan
2M ago
8K
ADIL
Adial Pharmaceuticals expects cash to fund operations into 2H of 2026
PremiumThe Fly
Adial Pharmaceuticals expects cash to fund operations into 2H of 2026
3M ago
ADIL
Adial Pharmaceuticals Secures European Partnership for AD04 Commercialization
PremiumCompany Announcements
Adial Pharmaceuticals Secures European Partnership for AD04 Commercialization
3M ago
8K
ADIL
Adial Pharmaceuticals enters collaboration framework agreement with Molteni
PremiumThe Fly
Adial Pharmaceuticals enters collaboration framework agreement with Molteni
3M ago
ADIL
Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program
PremiumCompany Announcements
Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program
4M ago
8K
ADIL
Adial Pharmaceuticals regains compliance with Nasdaq listing requirement
PremiumThe FlyAdial Pharmaceuticals regains compliance with Nasdaq listing requirement
4M ago
ADIL
Adial Pharmaceuticals highlights recent FDA policy, may reduce trial burden
Premium
The Fly
Adial Pharmaceuticals highlights recent FDA policy, may reduce trial burden
4M ago
ADIL
Adial Pharmaceuticals price target lowered to $8 from $37.50 at Maxim
Premium
The Fly
Adial Pharmaceuticals price target lowered to $8 from $37.50 at Maxim
4M ago
ADIL
Adial Pharmaceuticals trading halted, news pending
PremiumThe Fly
Adial Pharmaceuticals trading halted, news pending
4M ago
ADIL
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
4M ago
B
AIM
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today?
PremiumMarket News
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today?
4M ago
ADIL
Adial Pharmaceuticals Implements Reverse Stock Split to Regain Compliance
PremiumCompany Announcements
Adial Pharmaceuticals Implements Reverse Stock Split to Regain Compliance
4M ago
8K
ADIL
Adial Pharmaceuticals announces 1-for-25 reverse stock split
PremiumThe FlyAdial Pharmaceuticals announces 1-for-25 reverse stock split
4M ago
ADIL
Adial announces publication of international patent application for AD04
Premium
The Fly
Adial announces publication of international patent application for AD04
5M ago
ADIL
Adial Pharmaceuticals announces immediate resignation of board director
Premium
Company Announcements
Adial Pharmaceuticals announces immediate resignation of board director
5M ago
8K
ADIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >